Investment
Co-led a $34M Series D in Craif to bring its urine-based cancer test to the U.S. market.
Craif
Every public signal F4 has attached to this firm, with sources and cross-entity links.
Craif
Omio
Notta
Daloopa
Granite-Integral $100M joint venture